> top > docs > PMC:7534795 > spans > 22698-23063 > annotations

PMC:7534795 / 22698-23063 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T120 311-315 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T42 311-315 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T186 26-35 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T61281 311-315 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T18574 311-315 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T165 96-107 Chemical denotes ruxolitinib http://purl.obolibrary.org/obo/CHEBI_66919
T166 199-208 Chemical denotes vitamin C http://purl.obolibrary.org/obo/CHEBI_21241
T167 199-206 Chemical denotes vitamin http://purl.obolibrary.org/obo/CHEBI_33229

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T159 36-85 Sentence denotes • Primary outcome of time to clinical improvement
T160 86-123 Sentence denotes • N = 20 ruxolitinib + standard care
T161 124-188 Sentence denotes • N = 21 placebo + standard care • Ruxolitinib 5 mg twice daily
T162 189-293 Sentence denotes • Placebo vitamin C 100 mg twice daily • No difference in primary endpoint HR 1.669 (95% CI 0.836–3.335)
T163 294-350 Sentence denotes • Improvement in lung computerized tomography (CT) scans

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T93 19-35 Phenotype denotes severe infection http://purl.obolibrary.org/obo/HP_0032169